Scotiabank raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $450 from $433 and keeps a Sector Perform rating on the shares. The company had a strong Q4, with revenue beating ...

Everyone has their own rules for Super Bowl squares, but here at For The Win we’ve put together an easy-to-read — and printable! — template for you and your party to enjoy. Gambling involves ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Vertex Pharma could be close to succeeding in the long-standing quest to find an alternative to potentially addictive opioids for the treatment of pain associated with common medical procedures.

Showcase your company news with guaranteed exposure both in print and online 25 years ago, Denver's economy thrived on IT, real estate & oil. DBJ will kick… Be Inspired! Meet Your Mentor! Make ...

This release updates cesium-native from v0.44.1 to v0.44.2. See the changelog for a complete list of changes in cesium-native. This release updates cesium-native from v0.44.0 to v0.44.1. See the ...